Analystreport

La Jolla Pharmaceutical (NASDAQ: LJPC) was downgraded by analysts at J P Morgan Chase & Co from an "overweight" rating to an "underweight" rating.

La Jolla Pharmaceutical Company  (LJPC) 
Last la jolla pharmaceutical company earnings: 3/2 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: lajollapharmaceutical.com/investor-relations